A GLP-1 agonist is a medication that acts like the GLP-1 hormone in your body
The trial compared injectable semaglutide (1mg) once weekly with a placebo as an adjunct to the standard of care for the prevention of major kidney outcomes, specifically kidney failure, substantial loss of kidney function, and death from kidney or cardiovascular causes
Once a generic is deemed interchangeable in a given province, the insurer cuts back claims for the brand name drug to the cost of the lower-priced equivalent
Applicable Procedure Codes: 0094U, 0212U, 0213U, 0214U, 0215U, 0260U, 0264U, 0265U, 0266U, 0267U, 0318U, 0335U, 0336U, 0425U, 0426U, 0454U, 0469U, 0532U, 0567U, 0582U, 0583U, 0657U, 0658U, 0659U, 81354, 81415, 81416, 81417, 81425, 81426, 81427
Specifically, the Weight Care+ program includes: Access to GLP-1 prescriptions for qualified candidates Regular 1:1 virtual visits with a licensed clinician Quarterly at-home lab tests or supplements Lifestyle content and support for health conditions References Zeratsky K
They work gradually and do not produce the rapid laxative effect of osmotic agents like magnesium citrate or stimulant laxatives